MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

Condition:   Epidermolysis Bullosa
Interventions:   Drug: Thymoglobulin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Radiation: Total Body Irradiation;   Procedure: Bone marrow infusion;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil;   Biological: Donor mesenchymal stem cell infusions
Sponsor:   Masonic Cancer Center, University of Minnesota
Recruiting - verified February 2017